MARKET

NGEN

NGEN

Nervgen Pharma Corp
NASDAQ
1.810
-0.010
-0.55%
After Hours: 1.800 -0.01 -0.55% 18:26 06/09 EDT
OPEN
1.845
PREV CLOSE
1.820
HIGH
1.890
LOW
1.765
VOLUME
617.04K
TURNOVER
--
52 WEEK HIGH
6.30
52 WEEK LOW
1.765
MARKET CAP
192.23M
P/E (TTM)
-4.4222
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at NGEN last week (0601-0605)?
Weekly Report · 1d ago
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga · 6d ago
NervGen Pharma Raises US$60 Million in Underwritten Offering to Fund NVG-291 Program
TipRanks · 06/01 23:16
NervGen prices 24,000,000-share offering with warrants at US$2.5, targets US$60 million gross proceeds
PUBT · 06/01 21:30
Weekly Report: what happened at NGEN last week (0525-0529)?
Weekly Report · 06/01 09:06
Nervgen’s CONNECT Trial Termination: What It Means for NGEN Investors
TipRanks · 05/29 16:32
NervGen Reports Objective Neural Recovery Signal for NVG-291 in Chronic SCI Ahead of Phase 3
TipRanks · 05/26 21:17
NervGen Pharma Increases Mixed Shelf Offering From $150M To $250M
Benzinga · 05/26 13:31
More
About NGEN
NervGen Pharma Corp. is a clinical-stage biotech company. The Company is engaged in developing treatments to promote nervous system repair in the settings of neurotrauma and neurologic disease. NVG-291 is in a Phase 1b/2a clinical trial in spinal cord injury and has undertaken preclinical evaluation of a new development candidate, NVG-300, in models of ischemic stroke, amyotrophic lateral sclerosis (ALS) and spinal cord injury (SCI). Its NVG-291 is a therapeutic peptide targeting nervous system repair.

Webull offers NervGen Pharma Corp stock information, including NASDAQ: NGEN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NGEN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading NGEN stock methods without spending real money on the virtual paper trading platform.